GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like AbbVie Touts Late-Stage Psoriasis Drug Trial Data October 25, 2017 Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties February 1, 2018 Novo Nordisk’s Positive Phase III Data for Oral Diabetic Drug Heats Up the Competition February 21, 2018
Novo Nordisk’s Positive Phase III Data for Oral Diabetic Drug Heats Up the Competition February 21, 2018
